What is the recommended dose and timing of human Actrapid (fast-acting insulin) for an adult patient with diabetes, previously on Mixtard (biphasic insulin)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 28, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Actrapid (Regular Human Insulin) Dosing and Timing

Critical Timing Requirement for Actrapid

Actrapid (regular human insulin) must be injected 30 minutes before meals to achieve optimal postprandial glucose control, unlike rapid-acting insulin analogs which can be given 0-15 minutes before eating. 1, 2

Transitioning from Mixtard to Basal-Bolus Therapy

Calculate Total Daily Dose (TDD)

  • Add up all current Mixtard doses to determine your baseline TDD 3
  • For patients with severe hyperglycemia (A1C ≥9%), consider starting with 0.3-0.5 units/kg/day as TDD 3, 4
  • For metabolically stable patients, 0.5 units/kg/day is typical 3

Split Between Basal and Prandial Insulin

  • Divide TDD as 50% basal insulin (long-acting) and 50% prandial insulin (Actrapid) 3, 4
  • Distribute the prandial 50% equally among three meals (approximately 17% of TDD per meal) 3

Actrapid Administration Protocol

Injection Timing

  • Inject Actrapid 30 minutes before meal ingestion 2
  • This 30-minute interval is essential because regular insulin has a slower onset of action compared to rapid-acting analogs 1, 2
  • Surveys show 75% of patients use intervals <30 minutes, but optimal control requires the full 30-minute wait 2

Dosing Strategy

  • Start with calculated meal dose (approximately 17% of TDD per meal) 3
  • For patients not counting carbohydrates, use a stepped correction approach: add 2 units if pre-meal glucose >250 mg/dL, add 4 units if >350 mg/dL 3
  • For carbohydrate counting, use insulin-to-carbohydrate ratio of 1 unit per 10-15 grams initially 3

Titration Schedule

Adjusting Actrapid Doses

  • Increase prandial Actrapid by 1-2 units or 10-15% every 3 days based on 2-hour postprandial glucose readings 3
  • Target postprandial glucose <180 mg/dL 3, 5
  • If hypoglycemia occurs, reduce the corresponding dose by 10-20% immediately 3

Monitoring Requirements

  • Check pre-meal glucose before each Actrapid injection 3
  • Check 2-hour postprandial glucose to assess meal coverage adequacy 3
  • Daily monitoring is essential during titration phase 3

Critical Pitfalls to Avoid

Timing Errors

  • Never inject Actrapid immediately before or after meals - this timing is only appropriate for rapid-acting analogs like lispro or aspart, not regular insulin 1, 6, 5
  • Do not inject Actrapid at bedtime due to increased nocturnal hypoglycemia risk 3

Dosing Mistakes

  • Do not use Actrapid as monotherapy with sliding scale only - this leads to dangerous glucose fluctuations 3, 7
  • Do not continue escalating basal insulin beyond 0.5-1.0 units/kg/day without adequate prandial coverage 3

Medication Management

  • Continue metformin unless contraindicated when using insulin therapy 3, 4
  • Do not abruptly discontinue oral medications when starting insulin 7

Special Considerations

Hyperglycemic Patients

  • In hyperglycemic patients (glucose >250 mg/dL), injecting Actrapid 15-30 minutes before meals significantly improves postprandial glucose control compared to injection at mealtime 6
  • However, 30-minute pre-meal injection may cause late postprandial hypoglycemia in some patients, so 15-minute interval may be safer 6

Mixing Considerations

  • Actrapid (short-acting insulin) should not be mixed with lente insulins due to zinc binding that delays onset 1
  • Can be mixed with NPH insulin if needed, though separate injections are preferred 1
  • Never mix any insulin with insulin glargine 1, 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Initial Dosing for Lantus (Insulin Glargine) in Patients Requiring Insulin Therapy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Insulin management of type 2 diabetes mellitus.

American family physician, 2011

Research

EADSG Guidelines: Insulin Therapy in Diabetes.

Diabetes therapy : research, treatment and education of diabetes and related disorders, 2018

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.